Xlear Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Xlear

Access the complete profile.

Xlear Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	339112 Surgical & Medical Instrument Manufacturing
Additional NAICS Codes	325411 Medicinal & Botanical Manufacturing
Address	723 Auto Mall Dr American Fork, UT 84003

Note: Revenues for privately held companies are statistical evaluations.


Xlear's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Xlear's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Xlear is classified as operating in the Surgical & Medical Instrument Manufacturing industry, NAICS Code 339112.

Xlear Annual Revenue and Growth Rate

Xlear	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Xlear's revenues are gauged from an analysis of company filings.

Xlear's Income Statement (based on Industry Averages)

Xlear P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Xlear is developing and marketing. Xlear doesn't have any recent trademark applications, indicating Xlear is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
XYCHLOR Nasal spray preparations; oral spray preparations for the prevention and treatment of allergies; Decongestant nasal sprays; antihistamines; Allergy medications; Pharmaceutical preparations for treating allergies; Preparations for treating colds and the flu; medications for treating colds and the flu; nasal sprays for treating colds and the flu; Cough lozenges; Medicated lozenges; throat lozenges	01/24/2020
XYLICARE Tooth gels; infant tooth gels; toothpaste; non-medicated mouth rinse	07/10/2018
GO WASH YOUR NOSE Nasal sprays; nasal sprays including xylitol; retail and online retail sale of nasal sprays and nasal sprays including xylitol	06/24/2016

See all trademarks and details in the Full Report.

Market Share of Xlear's Largest Competitors

A competitive analysis shows these companies are in the same general field as Xlear, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
EMBECTA	Parsippany, NJ	100
STRUCTURE MEDICAL	Mooresville, NC	34
AUTOCAM MEDICAL DEVICES	Kentwood, MI	30
SCHARNBERG HOLDING	Des Moines, IA	26
SPECIALTY SURGICAL INSTRUMENTATION	Antioch, TN	24
MIDWEST INTERVENTIONAL SYSTEMS	Maple Grove, MN	19
VITA NEEDLE	Needham, MA	17
PYLANT MEDICAL	Grapevine, TX	17
MEDTEC	Orange City, IA	16

Nearby Competitors

These companies are similar in business line and location to Xlear. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
MERIT MEDICAL SYSTEMS	South Jordan, UT	100
ORTHO DEVELOPMENT	Draper, UT	10
UTAH MEDICAL PRODUCTS	Midvale, UT	5
VIA DIGITAL SOLUTIONS	Draper, UT	3
XLEAR	American Fork, UT	2
KT HEALTH	American Fork, UT	2

Future Competition: Xlear's Fastest Growing Competitors

These companies are in the same general field as Xlear and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)